Literature DB >> 11393290

Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells.

D Drudy1, D P O'Donoghue1, A Baird1, L Fenelon1, C O'Farrelly1.   

Abstract

Clostridium difficile is the most common cause of diarrhoea in hospitalised patients. Bacterial adherence to gut epithelial cells is a likely prerequisite to infection and toxin production. A novel flow cytometric method was developed for detecting adherence of C. difficile to human colonic and small intestinal epithelial cells (EC) and human intestinal cell lines. Small intestinal and colonic EC were isolated from biopsy specimens with mucolytic and chelating agents. Adherence of fluorochrome-labelled C. difficile to EC was measured by flow cytometry and was calculated as increase in median fluorescent intensity (deltaMFI). Cells with bacteria attached could be distinguished easily from cells alone or cells with unlabelled bacteria attached. Toxin-positive C. difficile adhered to colonic and small intestinal EC (deltaMFI mean 21.2 SD 16.7, n = 33 and 16.5 SD 20.7, n = 19 respectively). The toxin-negative strain also adhered to both epithelial cell types (deltaMFI 26.1 SD 32.5, n = 17 and 18.3 SD 31.3, n = 16). Adherence of toxin-positive C. difficile to the intestinal cell lines Caco-2 (deltaMFI 9.4 SD 4.4, n = 14) and HT29 (deltaMFI 8.1 SD 3.1, n = 12) was quantifiable, although at a significantly lower level than with primary colonic epithelial cells. Adherence of the toxin-negative strain was slightly lower, deltaMFI 6.5 SD 1.8, n = 9 with Caco-2 cells and deltaMFI 6.0 SD 2.0, n = 10 with HT29 cells. Adherence of C. difficile to epithelial cell lines was blocked with C. difficile antiserum, confirming specificity of adherence. In conclusion, flow cytometry is a useful approach to quantifying adherence of C. difficile to human colonic and small intestinal epithelial cells. Binding of toxin-negative as well as toxin-positive bacteria was detectable by this approach. Analysis of C. difficile adherence to target cells may have important implications for the understanding of the pathogenesis of C. difficile-related disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393290     DOI: 10.1099/0022-1317-50-6-526

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.

Authors:  Xiaonan Han; Shila Gilbert; Katherine Groschwitz; Simon Hogan; Ingrid Jurickova; Bruce Trapnell; Charles Samson; Jonathan Gully
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

Review 2.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

3.  Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues.

Authors:  Emanuela Calabi; Franco Calabi; Alan D Phillips; Neil F Fairweather
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

4.  Interaction between host cells and septicemic Salmonella enterica serovar typhimurium isolates from pigs.

Authors:  Nadia Bergeron; Jonathan Corriveau; Ann Letellier; France Daigle; Louise Lessard; Sylvain Quessy
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

5.  Regulation of intestinal barrier function by signal transducer and activator of transcription 5b.

Authors:  X Han; X Ren; I Jurickova; K Groschwitz; B A Pasternak; H Xu; T A Wilson; S P Hogan; L A Denson
Journal:  Gut       Date:  2008-08-07       Impact factor: 23.059

6.  Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027.

Authors:  Shi-Shun Zhong; Zhen-Shu Zhang; Ji-De Wang; Zhuo-Sheng Lai; Qun-Ying Wang; Ling-Jia Pan; Yue-Xin Ren
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

7.  Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier.

Authors:  Xiaonan Han; Elizabeth Mann; Shila Gilbert; Yanfang Guan; Kris A Steinbrecher; Marshall H Montrose; Mitchell B Cohen
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

Review 8.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

9.  Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Authors:  Hiba Kandalaft; Greg Hussack; Annie Aubry; Henk van Faassen; Yonghong Guan; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; Susan M Logan; Jamshid Tanha
Journal:  Appl Microbiol Biotechnol       Date:  2015-05-05       Impact factor: 4.813

10.  Immunization using GroEL decreases Clostridium difficile intestinal colonization.

Authors:  Séverine Péchiné; Claire Hennequin; Céline Boursier; Sandra Hoys; Anne Collignon
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.